X-ray inhibits FUT4-mediated proliferation in A549 cells by downregulating SP1 expression

Jin-Xiao Liang1, Wei Gao2, Wei-Tian Wei1

  • 1Department of Oncological Surgery, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, China.

Abstract

Insights

X-ray irradiation down-regulates Lewis Y antigen expression in lung cancer cells by affecting fucosyltransferase IV and SP1. This mechanism inhibits A549 cell proliferation, highlighting glycosylation's role in radiation therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Lewis Y antigen is a key biomarker in various cancers.
  • Understanding antigen modulation during radiation therapy is crucial for treatment optimization.

Purpose of the Study:

  • To elucidate the mechanism by which X-ray irradiation down-regulates Lewis Y antigen expression.
  • To investigate the impact of X-ray irradiation on A549 lung cancer cell proliferation and its underlying molecular pathways.

Main Methods:

  • Western blotting and Co-immunoprecipitation (CO-IP) were used to analyze protein expression and interactions.
  • Electrophoretic mobility shift assay and Cell Counting Kit-8 (CCK8) assessed DNA damage and cell proliferation.
  • Statistical analysis was performed using SPSS 11.5.

Main Results:

  • X-ray irradiation decreased the expression of fucosyltransferase IV and Lewis Y antigen in A549 lung cancer cells.
  • Irradiation-induced DNA damage led to increased poly-adenosinediphosphate-ribosylated Specific Protein 1 (SP1) levels.
  • Translocation of SP1 from the nucleus resulted in reduced expression of fucosyltransferase IV and Lewis Y.

Conclusions:

  • X-ray irradiation inhibits A549 lung cancer cell proliferation through the down-regulation of Lewis Y antigen.
  • The mechanism involves DNA damage, increased SP1, and subsequent decreased expression of fucosyltransferase IV and Lewis Y.
  • Glycosylation plays a significant role in the efficacy of radiation therapy for lung cancer.